share_log

HC Wainwright & Co. Reiterates Buy on Atara Biotherapeutics, Maintains $28 Price Target

Benzinga ·  Sep 26, 2023 06:35

HC Wainwright & Co. reiterates Atara Biotherapeutics (NASDAQ:ATRA) with a Buy and maintains $28 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment